lobbying_activities: 2973704
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2973704 | 11880880-cc49-4ab0-88ca-dcdfd2b6b8fe | Q1 | WEST FRONT STRATEGIES LLC | 401103493 | FRESENIUS KABI USA LLC | 2023 | first_quarter | PHA | Issues related to drug pricing; issues related to Biosimilars; issues related to competition. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2023-04-19T21:29:55-04:00 |